Resumo

MAYDANA, Mariano; ECHAZARRETA, Diego; ORTIZ, Lucia  e  PORTIS, Marcelo. Hipertensión arterial e insuficiencia cardíaca: Innovaciones terapéuticas. Insuf. card. [online]. 2020, vol.15, n.3, pp.76-83. ISSN 1852-3862.

About a third of adults in most communities have high blood pressure (HBP). In Argentina the records show a prevalence of 33.5%; where 44.6% are men and 25.9% are women. It is estimated that a third of the population with HBP is unaware that they suffer from it and half are under antihypertensive treatment; but only a quarter is well controlled. On the other hand, the epidemic of heart failure (HF) reaches approximately 61 million individuals worldwide, and is closely related to hypertension, this being the main etiology, especially in Europe and the United States. From here arises the link between both entities, already well known and with drugs endorsed for their treatment for a long time. Both HBP and HF (whether with preserved or reduced ejection fraction) are highly linked and prevalent pathologies in all communities. The latest advances in research lead us to consider that the greater the reduction in blood pressure values, a cascade of beneficial mechanisms for the cardiovascular system are generated that lead to frank clinical benefits. Now, are there new therapies that can guide the course of these patients or are there only new and stricter objectives with the drugs that we previously knew?

Palavras-chave : Hypertension; Heart failure; Epidemic; Pathophysiology; New concepts.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )